Skip to main content

TechCon SoCal 2026

Engineering the Next Era of Medicine: AI, mRNA, Gene Therapy, and Advanced Biologics

May
22
2026

Date: May 22, 2026

Location: San Diego, CA

On May 22, Tali Tuchin will be moderating a panel titled "Engineering the Next Era of Medicine: AI, mRNA, Gene Therapy, and Advanced Biologics" at TechCon SoCal. 

The next wave of life sciences innovation is being shaped by the convergence of AI, advanced therapies, precision oncology, mRNA platforms, gene therapy, and scalable biomanufacturing. This panel will explore how breakthrough science moves from the lab into commercial reality, and what it takes to navigate clinical validation, manufacturing, regulation, capital formation, and market adoption. The conversation will connect scientific ambition with practical execution—highlighting how founders, investors, and industry leaders are redefining what medicine can become over the next decade.

Featured panelists will include:

  • Kate Broderick, Chief Scientific and Innovation Officer, Artis BioSolutions
  • Paul Grint, Executive Chairman, CRISPRQC
  • Magda Marquet, Co-Founder, Acurion
  • Jan Karlseder, Vice President, Chief Science Officer, Salk Institute
     

Register for Event

Speakers

Tali M. Tuchin

Tali M. Tuchin

Moderator

Tali M. Tuchin is a Mintz Member who handles complex business and technology transactions, including patent licenses and assignments, research and development agreements, and collaboration agreements. Her clients range from start-ups to large public companies in a variety of sectors, including biotechnology, pharmaceuticals, diagnostics, medical devices, health care, energy, and technology.